Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type-2 Diabetes Mellitus (T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03071016
What this trial is testing

Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 2,000
Not applicableWithdrawnNCT00732147
What this trial is testing

Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM

Who this might be right for
Type 2 Diabetes
University of Maryland, Baltimore
Not applicableLooking for participantsNCT06852950
What this trial is testing

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus (T1DM)Hyperglycemia
Vanderbilt University Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT01441986
What this trial is testing

Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH 20
Not applicableActive Not RecruitingNCT07144670
What this trial is testing

Fat Around Heart Arteries as a Measure of Inflammation in Patients With Glycometabolic Disease

Who this might be right for
Obesity &Amp; OverweightObesity Type 2 Diabetes MellitusType 2 Diabetes (T2DM)+4 more
Odense University Hospital 747
Early research (Phase 1)Study completedNCT00768105
What this trial is testing

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin

Who this might be right for
Type 2 Diabetes
AstraZeneca 24
Not applicableStudy completedNCT06111508
What this trial is testing

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Who this might be right for
Type 2 Diabetes
University of Virginia 30
Early research (Phase 1)Study completedNCT01582308
What this trial is testing

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 22
Early research (Phase 1)Study completedNCT01165268
What this trial is testing

Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 24
Large-scale testing (Phase 3)Ended earlyNCT00970424
What this trial is testing

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Who this might be right for
Diabetes Mellitus, Type II
Forest Laboratories 252
Large-scale testing (Phase 3)Ended earlyNCT04606576
What this trial is testing

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 710
Very early researchStudy completedNCT05093517
What this trial is testing

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Who this might be right for
Type 2 DiabetesGlucose Tolerance ImpairedInsulin Sensitivity
The University of Texas Health Science Center at San Antonio 4
Early research (Phase 1)Study completedNCT02411825
What this trial is testing

Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 76
Large-scale testing (Phase 3)Study completedNCT01513369
What this trial is testing

Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency

Who this might be right for
Type 2 Diabetes MellitusIron Deficiency
GWT-TUD GmbH 152
Not applicableStudy completedNCT01523405
What this trial is testing

A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM

Who this might be right for
Type II Diabetes Mellitus
AstraZeneca 4,911
Not applicableStudy completedNCT04390711
What this trial is testing

Association of Carbamylated HDL and CAD in T2DM Patients

Who this might be right for
Type 2 Diabetes Mellitus With Circulatory Complciation
RenJi Hospital 282
Large-scale testing (Phase 3)Study completedNCT03954834
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 478
Early research (Phase 1)Looking for participantsNCT07463196
What this trial is testing

A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors

Who this might be right for
Healthy ParticipantsObesityType 2 Diabetes Mellitus (T2DM)
AC Immune SA 114
Not applicableNot Yet RecruitingNCT05925946
What this trial is testing

Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of T2DM

Who this might be right for
Diabetes MellitusPreDiabetesDiet Habit
Diabetes Foundation, India 60
Large-scale testing (Phase 3)UnknownNCT06141980
What this trial is testing

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Daewoong Pharmaceutical Co. LTD. 134
Next Page